LALPATH LABS FOR 3075

7월 4일

LAL PATHLABS is one of leading stocks of the labs sector, The main operation of Dr Lal PathLabs deals with the performing of diagnosis and testing, including routine tests (including blood tests), specialized tests (e.g., viral and bacterial infection tests) and preventive screenings.
As per latest news Dr Lal PathLabs is working on Newly spread zika virus antiodose,which may lead stock into high again.
We see a breakout on this stock.
CMP : 2900
SL : 2680
Target : 3075


Note : This is not any stock recommendation this is only for educational purpose.

8월 21일

거래청산: 타겟 닿음

T1 Hit - Trade closed